Intellectual Property and Technology Transfer Guidelines
Intellectual Property and Technology Transfer Guidelines
OFFICE OF RESEARCH
Inventions and Discoveries. Intellectual property and or materials of commercial value created by UW
investigators in the course of hESC research will be disclosed to UW CoMotion in accordance with the UW
Patent, Invention, and Copyright Policy. All intellectual property arising from human embryo and hESC
research shall be managed in accordance with the foregoing policy and the rules and procedures of UW
CoMotion Consistent with the foregoing, the UW recognizes that there may be instances in which it will be in
the public interest to place intellectual property arising from human embryo and hESC research in the public
domain for broad no-cost dissemination . Provided it does not conflict with any other agreements including
funding or internal UW agreements, and is not already under management by UW CoMotion, decisions in such
cases shall be made by UW inventors, creators, and/or authors after appropriate consultations with the principal
investigator and co-creators on the research.
Material Transfer Agreements. Incoming and outgoing transfers of human embryo and hESC, hESC lines,
hESC derived cell lines, hESC derivatives, and other materials where UW wishes to control downstream usage
and further distribution shall be documented through material transfer agreements approved by the UW
CoMotion MTA Group.
1
Final 3/1/2023